Delivery Order SPE2DB20D1004-SPE2DB23FF1R0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Famotidine 40 mg/5 ml suspension in 50 ml bottles. The contract has a firm fixed price of $1,418.31 and an ultimate completion date of September 16, 2024. This appears to be a delivery order under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,791.96, is for the delivery of Famotidine 40 mg/5 ml suspension with a completion date of December 16, 2022. The award is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,322.38 fixed-price delivery order is for the supply of 4555553878 – Famotidine 40 mg/5 ml suspension, 50 ml, with a completion date of December 1, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $2,100.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Famotidine 40 mg/5 ml suspension, a prescription medication used to treat conditions such as heartburn, acid reflux, and stomach ulcers. The contract has an ultimate completion date of September 19, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. This...
- This federal contract award, valued at $1,499.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566618142 - Famotidine 40 mg/5 ml Suspension, 50 ml, with an ultimate completion date of December 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,678.86 for the supply of Famotidine 40 mg/5 ml suspension in 50 ml bottles. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distribution company that specializes in providing a wide range of medical products and supplies to various government agencies, particularly the Department of Defense (DoD) and Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,339.18 firm fixed-price delivery order covers the supply of Famotidine 40 mg/5 ml suspension, a medication used to treat conditions such as heartburn and stomach ulcers. This award is not designated as a set-aside contract. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Famotidine 40 mg/5 ml suspension in 50 ml bottles. The contract has a ceiling value of $1,181.28 and a period of performance through March 20, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,794.84 firm fixed-price delivery order is for the pharmaceutical product Famotidine 40 mg/5 ml suspension, with a period of performance through July 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $1,755.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 50 ml of 40 mg/5 ml Famotidine suspension, a medication used to treat stomach and esophageal problems. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF1R0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4559813533 - Famotidine 40 mg/5 mL suspension 50 mL. The $2,132.89 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with DLA Troop Support Medical. This IDC, which runs through November 2026, enables DLA to efficiently procure a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care materials, to support military healthcare programs globally. The contract award was made through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/2/23 |